Nanobiotix is a late-stage clinical biotechnology company focused on developing innovative, physics-based nanotherapeutics for cancer treatment
Nanobiotix is a late-stage clinical biotechnology company focused on developing innovative, physics-based nanotherapeutics for cancer treatment. Their lead product, NBTXR3, is a radioenhancer for solid tumors.